AIM-AHEAD Welcomes 130 New Trainees and Launches 2025-2026 Collaborative Training Program Cohorts
The 2025–2026 AIM-AHEAD Collaborative Training Programs are now underway with the launch of their new cohorts last month.
Applications are open for the Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional (RFA-HG-24-026). This opportunity supports organizations interested in advancing scholarship and capacity in ELSI research related to advances in genetics and genomics.
Eligible applicants must be domestic organizations located in the United States and its territories that received less than $30 million per year in total NIH funding for the past three fiscal years (FY 2023–2025). Eligible applicants may propose partnerships with other organizations that receive more than $30 million per year in NIH funding.
Students and trainees are not eligible to apply. Organizations outside of the United States are not eligible to apply.
The goals of the Building Partnerships and Broadening Perspectives to Advance ELSI Research (BBAER) Program are to:
This program is funded by the National Human Genome Research Institute’s (NHGRI) ELSI Research Program. Since 1990, the ELSI Research Program has funded research, research training, resource development, and other activities addressing the ethical, legal, and social implications of advances in genetics and genomics.
Detailed application requirements and program information are available in the Notice of Funding Opportunity RFA-HG-24-026, which includes an overview diagram of all application elements. Frequently Asked Questions and a recorded program presentation are also available online.
Per NIH notice NOT-OD-26-019, letters of intent are no longer required. For additional questions or to discuss organizational interests, please contact Dr. Rene Sterling at rene.sterling@nih.gov.
The 2025–2026 AIM-AHEAD Collaborative Training Programs are now underway with the launch of their new cohorts last month.
Find out more about AIM-AHEAD Year 4 Programs and their Awardees and Fellows, along with each individual’s institutional and AIM-AHEAD Hub affiliations.
The aiMATCH team is preparing to launch the new Leukemia Patient Outcome Prediction Challenge in partnership with AIM-AHEAD, The University of Texas at San Antonio, and MD Anderson Cancer Center.